Delisting risk
GRI Bio (GRI)
Develops NKT-cell therapies for pulmonary fibrosis and autoimmune disease.
$2.03
Pre-market+0.03 (+1.50%)
At close$2.00(+4.71%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$0.94
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Aug '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$36.68−$36.69−$35.85−$5.34−$1.61−$1.61−$0.91Pending
Estimate−$1.31−$36.69−$31.09−$29.27−$0.91−$1.20−$1.19−$0.94
Surprise−2,700.0%0.0%−15.3%+81.8%−76.9%−34.2%+23.5%—
RevenueReportedEstimate
Aug '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate——$6.3M—————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.94 | — | — |
| Aug 2026 | −$1.19 | −$0.91 | +23.5% |
| Aug 2026 | −$1.20 | −$1.61 | −34.2% |
| May 2026 | −$0.91 | −$1.61 | −76.9% |
| Mar 2026 | −$29.27 | −$5.34 | +81.8% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Dec 2024 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| Jul 2022 | |||
| Jun 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.94 | — | — | — | — | — | — |
| Aug 14, 2026 | −$1.19 | −$0.91 | +23.5% | — | — | — | −5.7% |
| Aug 13, 2026 | −$1.20 | −$1.61 | −34.2% | — | — | — | −9.2% |
| May 13, 2026 | −$0.91 | −$1.61 | −76.9% | — | — | — | −4.9% |
| Mar 13, 2026 | −$29.27 | −$5.34 | +81.8% | — | — | — | +0.4% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 14, 2025 | |||||||
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Dec 16, 2024 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 10, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 24, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Nov 3, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Jun 30, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||